Orally active, cell-penetrating homing peptide and methods using same
US11524077B2 · kind B2 · utility
0Cited by
2References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 19, 2020 |
| Grant date | Dec 13, 2022 |
| Priority date | — |
| Expiry date | May 19, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are compositions and methods useful for oral delivery of targeted therapies for pulmonary diseases, fibrotic disorders and cancer. The compositions and methods are based on peptide sequences that selectively bind to and home to diseased tissue and enable targeted therapies to affect a beneficial therapeutic result. The disclosed targeting is useful for oral delivery of therapeutic and detectable agents to diseased tissue in an animal.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.